Published in Eur Urol on January 01, 1992
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (2003) 1.45
Human Papillomavirus: Confronting the Epidemic-A Urologist's Perspective. Rev Urol (2005) 0.86
Surgical treatment for 11 cases of penile verrucous carcinoma. Ann Dermatol (2011) 0.82
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut (2000) 3.83
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol (2002) 3.03
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol (2001) 2.87
Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol (1991) 2.13
Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut (1998) 1.98
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol (2000) 1.94
Turner phenotype with pelvic kidney and other unusual abnormalities. JAMA (1970) 1.80
Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol (1997) 1.60
Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group. Br J Urol (1995) 1.54
Male andropause: myth, reality, and treatment. Int J Impot Res (2002) 1.53
Handling and reporting of biopsy and surgical specimens of testicular cancer. Eur Urol (2004) 1.45
Congenital uro-nephropathies: is routine voiding cystourethrography always warranted? Clin Radiol (1998) 1.39
Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Am J Clin Pathol (1993) 1.38
Belgian consensus guidelines for follow-up of women with cervical cytological abnormalities. Acta Clin Belg (2009) 1.38
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone. Eur Urol (1982) 1.35
Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol (1997) 1.34
Fetal uropathies: diagnostic pitfalls and management. J Urol (1985) 1.24
In vitro study on mechanisms of bupivacaine-induced depression of myocardial contractility. Anesth Analg (1989) 1.23
Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma. J Clin Pathol (2002) 1.22
Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol (1998) 1.21
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J (1999) 1.20
Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases. Br J Dermatol (2000) 1.16
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases. Am J Clin Pathol (2000) 1.15
Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology (1997) 1.14
Venous leakage: surgical treatment of a curable cause of impotence. J Urol (1985) 1.14
Pathological changes in prostate lesions after androgen manipulation. J Clin Pathol (1998) 1.13
Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod (2000) 1.12
Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol (1983) 1.11
The chromosomes of the EB virus-positive Burkitt cell line P3J.HR1K studied by the fluorescent staining technique. Pathol Eur (1972) 1.11
Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. J Hepatol (1997) 1.11
Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology (1997) 1.11
Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases. Eur Urol (2001) 1.10
Endoscopic injections of Teflon to treat urinary incontinence in women. Br Med J (Clin Res Ed) (1984) 1.10
Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol (1997) 1.09
Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. Eur Heart J (1984) 1.09
Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant-induced hypersensitivity syndrome. Br J Dermatol (1998) 1.09
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer (1999) 1.08
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol (2003) 1.08
Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol (1998) 1.07
Objective quantification of cavernous endothelium in potent and impotent men. J Urol (1995) 1.07
Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer (1991) 1.05
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL. Urology (1999) 1.05
The single ectopic ureter. Eur Urol (1976) 1.02
Endoscopic biopsies of the papilla of Vater at the time of endoscopic sphincterotomy: difficulties in interpretation. Gastrointest Endosc (1984) 1.01
What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary? Eur Urol (2000) 1.01
Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol (1993) 1.01
Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol (1996) 1.00
The ureterovesical innervation. A new concept based on a histochemical study. Br J Urol (1972) 1.00
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate (2001) 1.00
Precursors of prostatic cancer: progression, regression and chemoprevention. Eur Urol (1996) 0.98
Does prostaglandin E1 therapy modify the intracavernous musculature? J Urol (2000) 0.97
Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation (1998) 0.97
Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis. Lung Cancer (1999) 0.95
What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer? Int J Cancer (2000) 0.95
Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology (1997) 0.95
Evidence of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma-like carcinoma of uterine cervix: report of two cases and review of the literature. Hum Pathol (2001) 0.95
[Analysis of the electrophysiological effects of amiodarone using simultaneous recordings of monophasic and bundle-of-his action potentials]. Arch Mal Coeur Vaiss (1976) 0.94
Demonstration of human papillomavirus type 2 in a verrucous carcinoma of the foot. Dermatology (1993) 0.94
Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology (2001) 0.93
Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis. Hepatology (2000) 0.93
Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy (2001) 0.93
Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer. Clin Exp Immunol (1997) 0.92
Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield. Eur Urol (2000) 0.91
Causes of death in patients with cancer. Eur J Cancer (1972) 0.90
Fracture of the penis: conservative versus surgical treatment. Eur Urol (1987) 0.90
Determination of cardiac and plasma drug levels during long-term amiodarone therapy. Eur J Clin Invest (1983) 0.90
Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features. Cancer (1996) 0.90
Biological markers in superficial bladder tumors and their prognostic significance. Urol Clin North Am (2000) 0.89
Early prostate cancer: prevention, treatment modalities, and quality of life issues. Eur Urol (2003) 0.89
The importance of measuring the prostatic transition zone: an anatomical and radiological study. BJU Int (1999) 0.89
Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis (1987) 0.88
Ectopic ureter emptying into the rectum: report of a case. J Urol (1972) 0.88
Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis. Anal Quant Cytol Histol (1992) 0.88
Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: a preliminary study. Histopathology (2004) 0.87
Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol (1989) 0.87
Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. Urology (1997) 0.87
[Study of monophasic action potentials of the myocardium using the endocavitary route and its applications]. Ann Cardiol Angeiol (Paris) (1976) 0.87
Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer. Eur J Cancer Clin Oncol (1989) 0.87
Characterization of gentamicin-resistant respiratory-deficient (res-) variant strains of Staphylococcus aureus. Microbiol Immunol (1990) 0.87
Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol (1993) 0.87
Can survival be prolonged for patients with hormone-resistant prostate cancer? Lancet (2001) 0.87
Parameters of erection. Br J Urol (1984) 0.86
Disrupted desmosomes in induced lesions of familial benign chronic pemphigus. J Cutan Pathol (1979) 0.86
Leukemia in a trisomy 21 mosaic: specific involvement of the trisomic cells. Cancer Genet Cytogenet (1986) 0.86
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer (2000) 0.86
In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer (1996) 0.86
Hepatocellular carcinoma metastatic to the parotid gland: initial diagnosis by fine needle aspiration biopsy. Acta Cytol (1998) 0.86
Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies. Clin Rheumatol (2000) 0.85
Retroperitoneal laparoscopic nephrectomy and other procedures in the upper retroperitoneum using a balloon dissection technique. Eur Urol (1994) 0.85
Hereditary intestinal neurofibromatosis. I. A distinctive genetic disease. Neurofibromatosis (1988) 0.85
Re: xanthogranulomatous pyelonephritis in childhood. J Urol (1977) 0.84
Transformation of common warts into squamous cell carcinoma on sun-exposed areas in an immunosuppressed patient. Dermatology (1994) 0.84